1 |
Schwandt P. Drug interactions and side effects of hypolipidemic drugs. Int J Clin Pharmacol Biopharm. 1979;17:351-356.
|
2 |
Alam N, Yoon KN, Lee JS, et al. Dietary effect of Pleurotus eryngii on biochemical function and histology in hypercholesterolemic rats. Saudi J Biol Sci. 2011;18:403-409.
DOI
|
3 |
Wadhera RK, Steen DL, Khan I, et al. A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality. J Clin Lipid. 2016;10:472-489.
DOI
|
4 |
Yoon KN, Alam N, Lee JS, et al. Antihyperlipidemic effect of dietary Lentinus edodes on plasma, feces and hepatic tissues in hypercholesterolemic rats. Mycobiology. 2011;39:96-102.
DOI
|
5 |
Wahl PW, Walden CE, Knopp RH, et al. Lipid and lipoprotein triglyceride and cholesterol interrelationships:effects of sex, hormone use, and hyperlipidemia. Metab Clin Exp. 1984;33:502-508.
DOI
|
6 |
Golomb BA, Evans MA. Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs. 2008;8:373-418.
DOI
|
7 |
Esmaillzadeh A, Azadbakht L. Food intake patterns may explain the high prevalence of cardiovascular risk factors among Iranian women. J Nutr. 2009;138:1469-1475.
|
8 |
Sodjinou R, Agueh V, Fayomi B, et al. Obesity and cardio-metabolic risk factors in urban adults of Benin: relationship with socio-economic status, urbanisation, and lifestyle patterns. BMC Public Health. 2008;8:1-13.
DOI
|
9 |
Endo A. The discovery and development of HMGCoA reductase inhibitors. J Lipid Res. 1992;33:1569-1582.
|
10 |
Olokoba AB, Obateru OA, Olokoba LB. Type 2 diabetes mellitus: a review of current trends. Oman Med J. 2012;27:269-273.
DOI
|
11 |
Ibrahim R. Diabetes mellitus type II: review of oral treatment options. Int J Pharm Pharmaceut Sci. 2010;2:21-30.
|
12 |
Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:1939-1951.
DOI
|
13 |
Laoufi H, Benariba N, Adjdir S, et al. In vitro -amylase and -glucosidase inhibitory activity of Ononis angustissima extracts. J Appl Pharmaceut Sci. 2017;7:191-198.
|
14 |
Ying JZ, Mao XL, Ma QM, et al. Icons of medicinal fungi from China. Beijing: Science Press;1987.
|
15 |
Pak WH, Lee HD. Illustrated book of Korean medicinal mushrooms. 2nd ed. Seoul: Kyo-Hak Publishing Co. Ltd; 2003.
|
16 |
Kim JS, Kwon CS, Son KH. Inhibition of -glucosidase and amylase by Luteolin, a flavonoid. Biosci Biotech Biochem. 2000;64:2458-2461.
DOI
|
17 |
Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497-509.
|
18 |
Dastjerdi MZ, Namjoyan F, Azemi ME. Alpha amylase inhibition activity of some plants extract of Teucrium species. J Biol Sci Opin. 2015;7:26-31.
|
19 |
Kim YS, Lee YM, Kim HJ, et al. Anti-obesity effect of Morus bombycis root extract: anti-lipase activity and lipolytic effect. J Ethnopharmacol. 2010;130:621-624.
DOI
|
20 |
Pietsch M, Gutschow M. Synthesis of tricyclic 1,3-oxazin-4-ones and kinetic analysis of cholesterol esterase and acetylcholinesterase inhibition. J Med Chem. 2005;48:8270-8288.
DOI
|
21 |
Bayliss HO. Lipids. In: Bancroft JD, Stevens A, editors. Theory and practice of histological techniques. Edinburgh: Churchill Livingstone;1990. p. 215-244.
|
22 |
Santhoshkumar S, Nagarajan N. In vitro antioxidant and antidiabetic activity of methanol extract of wild mushroom Ganoderma lucidum (Curtis) P. Karst. Int J Biosci Nanosci. 2014;1:77-85.
|
23 |
Su CH, Laib MN, Ng LT. Inhibitory effects of medicinal mushrooms on -amylase and aglucosidase-enzymes related to hyperglycemia. Food Funct. 2013;4:644-649.
DOI
|
24 |
Maqsood M, Ahmed D, Atique I, et al. Lipase inhibitory activity of Lagenaria siceraria fruit as a strategy to treat obesity. Asian Pac J Trop Med. 2017;10:305-310.
DOI
|
25 |
Slanc P, Doljak B, Mlinari A, et al. Screening of wood damaging fungi and macrofungi for inhibitors of pancreatic lipase. Phytother Res. 2004;18:758-762.
DOI
|
26 |
Lee JK, Jang JH, Lee JT, et al. Extraction and characteristics of anti-obesity lipase inhibitor from Phellinus linteus. Mycobiology. 2010;38:52-57.
DOI
|
27 |
Bobek P, Ozdin L, Kuniak L. Regulation of cholesterol metabolism with addition of oyster mushroom (Pleurotus ostreatus) in rats with hypercholesterolemia. Cas Lek Cesk. 1997;136:186-190.
|
28 |
Chiou SY, Lai GW, Lin G. Kinetics and mechanisms of cholesterol esterase inhibition by cardiovascular drugs in vitro. Indian J Biochem Biophys. 2006;43:52-55.
|
29 |
Alam N, Yoon KN, Lee TS, et al. Hypolipidemic activities of dietary Pleurotus ostreatus in hypercholesterolemic rats. Mycobiology. 2011;39:45-51.
DOI
|
30 |
Mori K, Kobayashi C, Tomita T, et al. Antiatherosclerotic effect of the edible mushrooms Pleurotus eryngii (Eringi), Grifola frondosa (Maitake) and Hypsizygus marmoreus (Bunashimeji) in apolipoprotein E-deficient mice. Nutr Res. 2008;28:335-342.
DOI
|
31 |
Golomb BA, Evans MA, Shimada Y, et al. Eritadenine induced alterations of plasma lipoprotein lipid concentrations and phosphatidylcholine molecular species profile in rats fed cholesterolfree and cholesterol-enriched diets. Biosci Biotechnol Biochem. 2003;67:996-1006.
DOI
|
32 |
Cheung PCK. The hypercholesterolemic effect of two edible mushrooms: Auricularia auricula (treeear) and Tremella fuciformis (white jelly-leaf) in hypercholesterolemic rats. Nutr Res. 1996;16:1721-1725.
DOI
|
33 |
Ramachandra SG, Ramesh V, Krishnamurthy HN, et al. Normal hematological and plasma biochemical parameters of the captive bonnet monkey (Maccaca radiata). Primates. 1998;39:127-134.
DOI
|
34 |
Johnston DE. Special considerations in interpreting liver function tests. Am Fam Physician. 1999;59:2223-2230.
|
35 |
Hyder MA, Hasan M, Mohieldein AH. Comparative levels of ALT, AST, ALP and GGT in liver associated diseases. Eur J Experi Biol. 2013;3:280-284.
|
36 |
Lunagariya NA, Patel NK, Jagtap SC, et al. Inhibitors of pancreatic lipase: state of the art and clinical perspectives. Excli J. 2014;13:897-921.
|